Overall rank by patents
#44,702
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 13 technology areas, active 2015–2015. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;).
The verdict
Axcelon holds 5 US patents across 13 technology areas, rank #44,702 of 50,000 tracked assignees.
Axcelon Biopolymers Corporation has been granted 5 US utility patents between 2015 and 2015, placing Axcelon Biopolymers Corporation at rank #44,702 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.8 claims per patent with primary concentration in A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;). As a Foreign Corporation, Axcelon Biopolymers Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Axcelon sits between AVL Software And Functions Gmbh (5 patents, rank #44,698) and Aygaz Anonim Sirketi (5 patents, rank #44,706) - the closest US assignees by grant volume. The composite Innovation Score of 32.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 5 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Axcelon Biopolymers Corporation's 21.8 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Axcelon Biopolymers Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
AVL Software and Functions GmbH
5 patents
AVVIO GMBH & CO KG
5 patents
AWDS TECHNOLOGIES SRL
5 patents
AWE Technologies LLC
5 patents
AXCEN PHOTONICS CORP.
5 patents
AXIOM
5 patents
AXTONE SPOLKA AKCYJNA
5 patents
AYGAZ ANONIM SIRKETI
5 patents
AXCELON BIOPOLYMERS CORPORATION
5 patents
What this shows Axcelon holds 5 patents at rank #44,702, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #44,702 in granted patent volume.
Other assignees with the most granted patents in Axcelon's primary technology class.
Axcelon's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
32 Top 60% higher than 40% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 100.0% |
Top 13 of 13 technology areas
Overall rank by patents
#44,702
Across all tracked assignees
32.0 out of 100
How to use this portfolio
Axcelon's 5 grants land it in the top 60% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.